Randomized trial of whey protein to prevent colorectal neoplasia

Randomized trial of whey protein to prevent colorectal neoplasia - Randomized trial of whey protein to prevent colorectal neoplasia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032746

Enrollment

266

Registered

2018-06-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal neoplasia

Interventions

Whey protein Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Person who agreed to participate in the trial with written form of consent 2.Nothing corresponds to excluding criteria

Exclusion criteria

Exclusion criteria: 1.Person who is under 20 years old 2.Person who is taking laxative, prostaglandin analog or NSAIDs 3.Person who has allergy for dairy products

Design outcomes

Primary

Measure	Time frame
After taking whey protein for 1 year, the prevention of colorectal neoplasia will be examined with colonoscopy.	—

Secondary

Measure	Time frame
Adverse events due to taking whey protein will be assessed in blood tests after 6 months and 1 year.	—

Countries

Japan

Contacts

Public ContactSeiji Arihiro

The Jikei University Katsushika Medical Center Division of Gastroenterology and Hepatology, Department of Internal Medicine

sarihiro@gmail.com03-3603-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026